Barcode Specimen Labeling: A Practical Guide for Labs and Practices

Barcode specimen labeling links each tube, slide or container to one patient and one order, so the specimen can be verified by scan instead of by eye at every handoff. For practices and research sites, it is one of the most effective ways to prevent patient-specimen identification errors. A CDC-reviewed body of evidence found that manual entry systems were about 4.4 times as likely to produce identification errors as barcoding systems (CDC Laboratory Medicine Best Practices summary). This guide covers what the label should hold, where to scan, what U.S. requirements say, and how to set up a workflow that holds up in daily use.

TL;DR

• Barcode labeling reduces mislabeling and identification errors: a systematic review of 17 studies found every one favored barcoding.
• A good label carries a unique identifier in a scannable barcode, a human-readable identifier, and the specimen type. Patient name placement and label size follow the CLSI AUTO12 standard.
• Scan at collection, at lab receipt, and wherever custody or physical form changes, such as aliquoting or storage.
• CLIA requires written labeling procedures. The Joint Commission accepts barcodes that carry two or more person-specific identifiers.
• Printers, scanners, networks and your LIS or EHR connection matter as much as the label itself.

Why barcode specimen labeling matters

A mislabeled specimen is more than a rejected tube. It can mean a recollection, a delayed diagnosis or, in the worst case, a result attached to the wrong patient. Handwritten labels and manual data entry leave room for transposed digits, mixed-up tubes and illegible names.

The evidence for barcoding is consistent:

• Systematic review. A review and meta-analysis of 17 observational studies (10 on patient specimens, 7 on point-of-care testing) found that all favored barcoding. The authors concluded that barcoding reduces identification errors across diverse hospital settings, with a high strength of evidence (Snyder et al., PMC).
• Effect size. In the CDC summary, manual entry was about 4.4 times as likely as barcoding to cause patient-specimen identification errors, and nearly 6 times as likely in point-of-care testing (CDC).
• Multihospital results. A Pennsylvania Patient Safety Authority collaborative found baseline blood specimen labeling error rates of 0.1 to 4.1 per 1,000 opportunities. After interventions, errors fell by an aggregate 37% over 18 months (Pennsylvania Patient Safety Authority).
• A single-site example. In a community teaching hospital, barcode scanning combined with bedside label printing cut mislabeled specimens from 0.0250% to 0.0023%, and collections taking longer than 60 minutes fell by 22% (Walden University dissertation).

The last example is worth a closer look. That hospital already followed best practice: two patient identifiers and preprinted labels. Mislabeling still occurred roughly once or twice a month. Good habits are the foundation, and barcode verification adds a safeguard on top of them.

What belongs on a specimen barcode label

A label has two jobs: let a scanner identify the specimen, and let a person confirm it at a glance if the scanner is not available.

Core elements

For research biobanking, the NIA Aging Research Biobank guide calls for a single label per vial with three things: a unique vial identifier barcode, an eye-readable vial identifier, and the material type, such as serum, plasma, whole blood, urine or DNA (NIA guide, January 2024). Clinical labels typically add patient identifiers, collection date and time, and the collector’s identification, depending on your policy.

Layout and size

The CLSI standard AUTO12 sets a standard specimen label size of 2 × 1 inches (50.8 × 25.4 mm). It puts the patient’s name in the top left corner as the most important element, and it sets rules for truncating long names, barcode location and size, and label orientation on the tube (CLSI AUTO12). Following one layout across your sites means staff always look in the same place.

Built for the storage conditions

If specimens go into a freezer, the label has to survive it. The NIA guide states that labels for long-term storage at -80°C or -180°C must be specifically designed and tested for those conditions (NIA guide). For anything that will be frozen, shipped or exposed to chemicals, confirm the label stock and adhesive match the use before you order in volume. Our cold chain management guide covers the transport side of that question.

Where to scan: the checkpoints that matter

A barcode only protects you where it is scanned. The aim is a scan at every point where the specimen could be confused, without making staff scan so often that they stop paying attention.

A hospital LIS implementation guide describes a minimum useful set of checkpoints: collection, receipt into the laboratory, and placement on the analyzer or bench. It adds more checkpoints where custody or physical form changes, such as dispatch from a branch, arrival at a referral laboratory, centrifugation, aliquoting and storage placement (Healudoc implementation guide).

Two details deserve attention. First, aliquots should carry their own barcode linked to the parent accession. The NIA guide requires that each specimen (parent) be tracked and linked to any aliquot or derivative (child) in a validated inventory system capable of tracking at the vial level (NIA guide). Second, the last scan defines the search when a specimen goes missing, so a consistent checkpoint at every custody change shortens that search considerably.

How to print, apply and verify a label

The sequence matters as much as the technology. A workable version for a collection site looks like this:

1. Identify the patient using at least two identifiers, with the patient present.
2. Scan the patient’s wristband or order so the system retrieves the right record.
3. Print the label at the point of collection, not in advance and not in another room.
4. Inspect the label for print quality and enough white space around the barcode for it to scan. The NIA guide requires examining labels and barcodes before applying them, and testing that the barcode scans reliably for everyone who will handle the specimen (NIA guide).
5. Label the container in the patient’s presence and confirm the label against the patient before leaving.
6. Scan again if your workflow includes a confirmation scan, then record collection date and time.

The design of the system can enforce this order. In the hospital study above, the system could not print a label without a patient-verification scan, and laboratory staff were trained not to accept specimens that had not been collected with the system, so workarounds did not take hold (Walden University dissertation). The principle applies at any size: make the correct path the easy path, and make receiving staff consistent about what they accept.

Equipment and systems you need

A barcode workflow is a chain of small components, and any one can stall it.

• Label printers suited to your label stock, at every collection point.
• Scanners that read your barcode symbology reliably, including on curved tubes.
• Computers or mobile devices at the point of collection.
• A reliable network, wired or wireless.
• A laboratory information system (LIS) and, for practices, an EHR connection so orders, labels and results stay tied to the same record.

The CDC summary names label printers, computers, batteries and wireless networks as equipment that must be kept in good working order for barcoding implementation to succeed (CDC). A dead handheld battery or a dropped Wi-Fi connection pushes staff back to handwriting, which is exactly where errors return. Stock spare label rolls and ribbons, and keep a downtime procedure written down and rehearsed.

For research collections, the NIA guide adds that the inventory system should be validated, capture collection, processing, shipping and storage data for each vial, and go through an initial qualification process (NIA guide).

U.S. requirements and guidance

Labeling sits under several overlapping layers. Which apply depends on your setting.

CLIA

Under 42 CFR §493.1242, a laboratory must establish and follow written policies and procedures for specimen labeling, including the patient name or unique patient identifier and, when appropriate, the specimen source. It must also document the date and time it receives a specimen (eCFR). The related requisition rule, §493.1241, calls for the patient’s name or unique identifier, sex, age or date of birth, the tests ordered, the specimen source when appropriate, and collection date and, if appropriate, time (CMS/HHS, 2021 edition).

CLIA §493.1232 goes further, requiring procedures that ensure positive identification and optimum integrity of a specimen from collection or receipt through testing and reporting. The CDC recommends using at least two unique patient-specific identifiers (CDC Laboratory Quality). If you want the broader picture of what CLIA certification involves, see our guide for CLIA-certified laboratory managers.

The Joint Commission

For accredited hospitals, National Patient Safety Goal NPSG.01.01.01 requires at least two patient identifiers when collecting blood samples and other specimens for testing. The patient’s room number or physical location is not an identifier (Joint Commission NPSG, January 2024).

The Joint Commission’s FAQ states that electronic identification technology, such as barcoding or RFID, that includes two or more person-specific identifiers is an acceptable form of patient identifier. The intent is met when the patient is correctly identified with two identifiers and containers are labeled with two identifiers in the patient’s presence. It also clarifies that a wristband is a place where identifying information is located, and that the information on the band is the identifier (Joint Commission FAQ).

CLSI standards

CLSI PRE01 covers patient and specimen identification, collection, transport and handling for most medical laboratory specimens. It is written for those who collect, label and process specimens, and for people who manage identification and labeling processes or validate electronic patient ID systems (CLSI PRE01). Pair it with AUTO12 for label content and layout. Our own sample labeling standards guide walks through how these pieces fit together for U.S. compliance.

Label context matters beyond specimens too. Research teams that handle compounds as well as patient samples will see the same principle in how semaglutide FDA labels differ by product: what a label says determines how the material is handled.

Preventing errors and handling exceptions

Technology does not carry an implementation alone. The CDC workgroup identified support and involvement from all relevant departments and leaders, including nursing, laboratory and information systems, as a critical factor for successful barcoding. It also noted that process design appears more complex for surgical pathology than for routine laboratory or point-of-care testing (CDC). If you send pathology specimens, plan the label design for slides, cassettes and containers separately from your blood tube workflow.

A short list of habits keeps a barcode program healthy:

• Write an exception policy. Define what happens when a label will not scan, a printer fails or a patient has no wristband. Make the manual fallback documented, not improvised.
• Train receiving staff to apply one standard. A lab that accepts unlabeled or handwritten specimens teaches collectors the new process is optional.
• Track your own error rate. Count rejected and relabeled specimens monthly by site and collector, and share the trend.
• Test scannability whenever you change label stock, printer or tube type.
• Keep an audit trail of who collected, labeled and handed off each specimen.

Barcode labeling across different settings

Primary care and urgent care. Volume is high and collections happen in exam rooms. Printing the label in the room, after scanning the patient record, avoids pre-labeled tubes sitting on a counter.

Specialty practices. Test menus are broader, with more tube types and send-out tests. Standardizing label layout across tube types reduces confusion.

Skilled nursing and home health. Collections occur away from a fixed lab. Portable printers and mobile devices make point-of-collection labeling possible, and a courier handoff scan documents custody on the way to the lab.

Clinical trials. Protocols often require kit-specific labels, visit identifiers and aliquot labeling in freezer-safe stock. Our guide to clinical trial specimen pickup explains how sites and sponsors keep logistics aligned with these requirements.

Perspective: labeling is where lab partnership shows up

We see labeling as the first place a practice and its laboratory either work well together or don’t. A specimen can only be as reliable as the identification it carries on the way in.

That is why we focus on the whole path, not just the test. Our services include specimen pickup and transportation, mobile phlebotomy, electronic results reporting and LIS integration, so identification can stay consistent from collection to report.

Unlike large national laboratories, where providers may find turnaround slow and service impersonal, we prioritize direct communication and customized solutions. When your staff has a labeling question, you should be able to reach someone who knows your workflow.

Our advice: choose one label standard, scan at each custody change, and agree with your laboratory partner on what happens when something does not scan.

Kohealth Labs

How KoHealth Labs supports your specimen workflow

If you are choosing a laboratory partner, or adding one for specialized testing, the handoff between your site and the lab is where a clear process pays off. KoHealth Labs serves physicians, practices, healthcare facilities, research sponsors and CROs with clinical laboratory testing, molecular and PCR diagnostics, specimen pickup, mobile phlebotomy, electronic results reporting and LIS integration, with dedicated onboarding and training.

Practices can start with our family medicine laboratory services or pathology laboratory services pages, or reach us through KoHealth Labs to talk through your labeling and specimen handoff needs.

FAQ

Does CLIA require barcode labels on specimens?

No. CLIA requires written policies and procedures for specimen labeling, including the patient name or unique identifier, and documentation of the date and time of receipt. It does not mandate barcodes. Many laboratories choose barcodes because they make those procedures easier to follow and verify.

Is a barcode on a wristband enough to identify a patient?

The Joint Commission accepts barcoding or RFID as an identifier when it includes two or more person-specific identifiers. Its guidance says the information on the band is the identifier, not the band itself. Check your accreditor’s current wording for your setting.

What size should a specimen label be?

CLSI AUTO12 specifies a standard label size of 2 × 1 inches (50.8 × 25.4 mm), with the patient’s name in the top left corner. Your tube size and printer may require adaptations, so confirm the barcode remains scannable on the actual container.

Where should staff scan the barcode?

At minimum: collection, receipt into the lab, and the analyzer or bench. Add scans where custody or form changes, such as dispatch, aliquoting and storage. Choose checkpoints you will actually use, so staff do not batch-scan at the end of a shift.

How do aliquots get labeled?

Each aliquot should have its own barcode linked to the parent specimen in your tracking system. That lets you tell later which tube produced a given result. The NIA guide describes this parent-and-child tracking for research collections.

Sources

• CDC Laboratory Medicine Best Practices: barcoding summary
• Pennsylvania Patient Safety Authority: Reducing Errors in Blood Specimen Labeling
• Walden University dissertation on point-of-care barcode scanning and label printing
• Snyder et al., Effectiveness of Barcoding for Reducing Patient Specimen and Laboratory Testing Identification Errors
• CLSI AUTO12: Specimen Labels
• NIA Aging Research Biobank collection guide
• LIS barcode specimen tracking implementation guide
• eCFR: 42 CFR 493.1242
• CMS/HHS: 42 CFR Part 493 (2021 edition)
• CDC Laboratory Quality: collecting specimens
• CLSI PRE01: Patient and Laboratory Specimen Identification
• Joint Commission National Patient Safety Goals, January 2024
• Joint Commission: Two Patient Identifiers FAQ

For more information about our diagnostic testing, clinical research laboratory services, or partnership opportunities, visit https://kohealthlabs.com or contact KoHealth Labs at (469) 792-8439 and ask for Amy Patterson.